16677457ACTIVE
Incorporated: 2025-08-28
SIC: 72110
Last updated: 4 Nov 2025
ALTx Therapeutics develops oncology drugs that inhibit the alternative lengthening of telomeres (ALT Sign up to read more
| Allotment | Filed | Share Class | Round Size | Round Type |
|---|---|---|---|---|
2025-11-04 | £4.5M |
Companies with the most similar business descriptions.
Accounts not filed